Quantum Small Cap Fund
Direct · GrowthAI Summary
Quantum Small Cap Fund has underperformed its benchmark over longer horizons, with a 3Y lump-sum CAGR of 10.65% versus 12.05% for the NIFTY SMALLCAP 250, and negative alpha of -0.63% over 5Y widening to -1.55% over 15Y. Its SIP XIRR of 9.15% over 1Y and 8.85% over 3Y trails the category averages of 17.77% and 20.26% respectively by a wide margin. The only bright spot is the 1Y period, where the fund's 6.08% CAGR beat the benchmark's 3.33% with alpha of 2.32%.
The fund exhibits defensive behavior with a beta of 0.69 over longer periods, capturing only 70.22% of upside and 68.63% of downside moves, which cushions losses but also limits rally participation. Two drawdown events exceeding 10% occurred, with the maximum drawdown lasting 179 days and taking 98 days to recover. The 1Y Calmar ratio of 0.47 suggests modest risk-adjusted returns relative to the drawdown endured.
The portfolio holds 56 stocks with a well-diversified top 10 accounting for roughly 26% of NAV, led by Supriya Lifescience at 3.97% and Engineers India at 3.2%. Auto Components is the largest sector exposure at 13.9%, followed by Banks at 11.3% and Industrial Products at 9.2%, providing a spread across cyclical and defensive sectors. No single holding exceeds 4% of NAV, indicating a conservative, broadly diversified small-cap approach.
The fund sits in the bottom tier of its category, with SIP XIRR trailing category averages by roughly 8-11 percentage points across 1Y and 3Y windows. Its consistent negative alpha over 5Y through 15Y periods suggests persistent underperformance versus the benchmark rather than a temporary lag. The recent 1Y outperformance of 2.32% alpha offers a possible inflection, but the long-term record remains weak.
This fund suits conservative small-cap investors who prioritize downside protection and lower volatility over maximum returns, given its low beta and balanced capture ratios. A horizon of at least 7-10 years is advisable for small-cap exposure, though investors should weigh the fund's long-term underperformance against peers. Those seeking category-leading small-cap returns may find better alternatives elsewhere.
- Low beta of 0.69 with downside capture of 68.63%, providing better downside protection than the benchmark
- Recent 1Y alpha of 2.32% with fund CAGR of 6.08% beating the benchmark's 3.33%
- Diversified portfolio of 56 stocks with no single holding above 4% of NAV
- SIP XIRR of 8.85% over 3Y trails the category average of 20.26% by over 11 percentage points
- Persistent negative alpha from 5Y through 15Y periods, indicating long-term underperformance versus the NIFTY SMALLCAP 250
Generated on 13-10-2026, 3:10 AM. Verify before investing.
Gives more importance to longer time periods (10Y, 20Y) than shorter ones (1Y, 3Y). This balances out recent outperformance and gives a more realistic picture of what long-term returns might look like.
The largest peak-to-trough decline in the fund's NAV. Shows the worst-case loss an investor would have experienced at any point in the fund's history.
If you invested ₹1,00,000 every month via SIP, here's how this fund has historically performed across different time horizons.
| Duration | Invested | Median Value | XIRR | Min XIRR | Max XIRR |
|---|---|---|---|---|---|
| 1 Year | ₹12.00 L | ₹12.67 L | 9.0% | -22.0% | 32.3% |
| 3 Years | ₹36.00 L | ₹40.88 L | 8.8% | 7.7% | 9.8% |
SIP returns vs benchmark & category
Annualised SIP return (XIRR) over each rolling horizon — like-for-like, not lump-sum.
| Duration | Fund SIP XIRR | NIFTY SMALLCAP 250 | Category avg | Fund edge |
|---|---|---|---|---|
| 1 Year | 9.0% | 21.9% | 17.8% | -12.9% |
| 3 Years | 8.8% | 15.2% | 20.2% | -6.5% |
| Duration | Mean | Median | Min | Max | Sharpe | Sortino | % Positive | Cat. Mean | Cat. Median |
|---|---|---|---|---|---|---|---|---|---|
| 1 Year | 8.6% | 8.0% | -1.9% | 25.9% | 0.36 | 0.87 | 96% | — | — |
Calmar Ratio by Duration
Compared against NIFTY SMALLCAP 250
| Duration | Alpha | Beta | Upside Capture | Downside Capture | Fund CAGR | Bench CAGR |
|---|---|---|---|---|---|---|
| 1 Year | +3.16 | 0.86 | 85.9% | 81.4% | 6.7% | 3.0% |
| 3 Years | +0.56 | 0.69 | 70.3% | 68.5% | 11.0% | 12.2% |
| 5 Years | -0.48 | 0.69 | 70.3% | 68.5% | 6.5% | 7.1% |
| 7 Years | -0.92 | 0.69 | 70.3% | 68.5% | 4.6% | 5.0% |
| 10 Years | -1.25 | 0.69 | 70.3% | 68.5% | 3.2% | 3.5% |
| 12 Years | -1.37 | 0.69 | 70.3% | 68.5% | 2.6% | 2.9% |
| 15 Years | -1.50 | 0.69 | 70.3% | 68.5% | 2.1% | 2.3% |
| # | Stock | % of NAV |
|---|---|---|
| 1 | Supriya Lifescience Ltd | 3.97% |
| 2 | Engineers India Ltd | 3.20% |
| 3 | Uniparts India Ltd | 2.75% |
| 4 | Karur Vysya Bank Ltd | 2.71% |
| 5 | GNA Axles Ltd | 2.70% |
| 6 | Lumax Auto Technologies Ltd | 2.56% |
| 7 | Star Health And Allied Insurance Company Ltd | 2.50% |
| 8 | CCL Products (India) Ltd | 2.40% |
| 9 | Carysil Ltd | 2.30% |
| 10 | Afcom Holdings Ltd | 2.27% |